Prostep Nicotine Patch 
We can help you kick your chewing tobacco habit. In addition to cleaning teeth and treating bad breath and puffy, swollen gums associated with tobacco use, we may decide to prescribe a variety of nicotine replacement therapies, such as the transdermal nicotine patch or chewing gum that helps to wean addicted snuff dippers or tobacco chewers.
Prostep Nicotine Patch
Nicotine patches are worn for 24 hours over several weeks, supplying a steady flow of nicotine. Four of the major brands of patches are Habitrol, Nicoderm, Nicotrol and Prostep. Over the course of treatment the amount of nicotine in the patch decreases. The nicotine patch has a 25 percent success rate. Or you may try nicotine gum therapy on your quit day. One piece of gum is slowly chewed every 1-2 hours. Each piece should be discarded after 20-30 minutes.
For those who yearn to break their cigarette addiction but don't fancy a trip to the doctor's office, the ability to get the nicotine patch without a physician's prescription may be just what the doctor ordered.
Less than 10 years ago, the nicotine patch was available by prescription only. However, since 1996, nicotine drug products for use as "stop smoking aids" have been available without a prescription. In February 1996, the Food and Drug Administration approved the "switch" of Nicorette gum to over-the-counter (OTC) status. In the summer of 1996, the FDA also approved the prescription-to-OTC switch of two transdermal nicotine patch products (Nicotrol in July 1996 and NicoDerm CQ in August 1996). Switches of other nicotine patch products followed (Prostep in December 1998 and Habitrol in November 1999). In October 2002, the FDA approved Commit, the first lozenge dosage form containing nicotine.
The patch, gum, and lozenge join more than 700 other OTC drugs that would have required a prescription only 20 years ago, according to the Consumer Healthcare Products Association (CHPA), which represents the leading manufacturers and distributors of OTC medicines and nutritional supplements. The 700-plus products are now available without a prescription because the FDA, in cooperation with panels of outside experts, determined they could be used safely and effectively without a doctor's supervision.
The FDA believes that, in some cases, consumers can get more information in the OTC labeling than they would get from their doctors. For the nicotine patch, the package contains not only a drug that relieves withdrawal symptoms, but also behavioral modification information. The package provides an element of support that studies showed some people weren't getting from their doctors, by telling them when they'll most likely feel the urge to smoke, what they can do in place of smoking, and where they can go for support.
We can help you kick your chewing tobacco habit. First, we can clean your teeth and treat the bad breath and puffy, swollen gums associated with tobacco use. Then, we may decide to recommend a variety of nicotine replacement therapies. These include transdermal nicotine patches or chewing gum to help wean addicted tobacco users.
Nicotine patches are worn for 24 hours over several weeks, supplying a steady flow of nicotine. Four of the major brands are Habitrol, Nicoderm, Nicotrol, and Prostep. Throughout treatment, the amount of nicotine in the patch decreases. The nicotine patch typically has a 25 percent success rate. Or, you may try nicotine gum therapy to assist in kicking the habit. Chew one piece of gum every 1-2 hours, discarding after 20-30 minutes. (Use as directed on the product packaging.)
The NicoDerm CQ Patch releases nicotine that passes through the skin and into the body, helping to reduce nicotine withdrawal symptoms and cravings. The NicoDerm CQ Patch is very thin and uses special material to control how fast nicotine passes through the skin. Unlike cigarettes, NicoDerm CQ delivers a lower and relatively steady amount of nicotine throughout the 16- or 24-hour period that your patients are wearing the patch. This allows them to gradually reduce their need to smoke.
If you smoke every day, you are probably physically dependent on nicotine. You will have withdrawal symptoms when you stop smoking. You may become irritable and agitated, have trouble sleeping, have difficulty concentrating or experience mood swings. These withdrawal symptoms are often the reason smokers give up their effort to quit. Your family doctor can tell you about medications that help people quit smoking. One or more of these medications may be right for you:
-term addiction to nicotine than people who start smoking later in life. It is estimated that approximately 4.5 million adolescents in the United States are smokers. And many of them continue to smoke regularly as adults, increasing their risk of dying prematurely from smoking-related diseases, such as lung cancer, heart disease, and stroke.
The demand for transdermal nicotine patches in the USA has now reached such a high level that the manufacturers are struggling to maintain supplies. As the availability of smoking cessation patches has dwindled, consumers are switching between products, despite efforts by the companies to cultivate brand loyalty in this fledgling market.
The reports, from Sturdy Memorial Hospital in Attleboro, Mass., have triggered concerns about the safety and proper use of the patches. Available only by prescription, the patches have been widely promoted to both physicians and the public since they became available in the United States in late 1991.
The hospital would not say which brands of patches had been used by the patients, although more than one brand was used. Shea said one of the patients had died, but that the death appeared to be unrelated to the heart attack. All of the cases have occurred since April 1.
Four brands of nicotine patches are marketed in the United States. They are Habitrol, manufactured by Ciba-Geigy Corp.; Nicoderm, manufactured by Marion Merrell Dow Inc.; Nicotrol, made by Parke-Davis, a division of Warner-Lambert Co.; and ProStep, made by Lederle Laboratories.
All of the patches contain nicotine, which enters the bloodstream through the skin. The patches, meant for hard-core smokers who have been unable to quit by other methods, are to be used along with a comprehensive smoking cessation program.
Over a period of years, nicotine and other chemicals in cigarette smoke contribute to the development of atherosclerosis, the deposition of fatty particles in arteries, including those supplying blood to the heart. A heart attack can develop when these blood vessels become blocked.
Nicorette is a branded over-the-counter palliative treatment which is used to ameliorate the withdrawal effects involved in quitting smoking. It was part of Pfizer Consumer Healthcare Products Company, which was sold to Johnson & Johnson in 2006. Originally available as a patch for topical application, it was later made available as a nicotine gum (composed of nicotine polacrilex) lozenge, inhaler, and nasal spray. All these products contain nicotine as the active ingredient and work by delivering this into the bloodstream. These treatments are commonly referred to as nicotine replacement therapies.
Commit lozenges are an oral palliative aid in the cessation of smoking. Formats of both 4 mg (for those who smoke their first daily cigarette within 30 minutes of waking) and 2 mg (for those who wait more than 30 minutes before the first daily dose of nicotine), are available. The lozenges, which are of a minty flavour, are meant to be taken orally at least nine times a day during the first two weeks after a nicotine user is willing to quit using tobacco products.
Nobody says that quitting smoking is easy. The nicotine in cigarettes exerts a physical and mental hold on the smoker that presents a formidable barrier to quitting. For some people, nicotine is as addictive as heroin or cocaine, according to the U.S. Agency for Health Care Policy and Research.
It is not surprising, therefore, that fewer than 25 percent of smokers are able to quit on the first attempt, Cravings for a cigarette make life intolerable for many smokers. Withdrawal symptoms like irritability, anxiety, headache, depression, lack of concentration and restless-ness overcome will power and cause relapse. Today, however, there are a host of nicotine replacement products that can help smokers reduce their craving and withdrawal symptoms. In fact, studies found that using a nicotine replacement therapy can double the chances of quitting. Some products like the nicotine patch and nicotine gum are available in over the-counter forms while others like nicotine nasal spray and nicotine inhalers are available by prescription only. The FDA approved these nicotine replacement products after initial trials showed they were safe and effective.
The FDA approved the nicotine patch, which looks like an adhesive bandage, as a prescription in 1993, Four years later it became available in over-the-counter forms. The nicotine patch releases a constant amount of nicotine through the skin. It is applied every morning to a different area of dry, non-hairy skin for about 16 to 24 hours. Most people us the patch for 6 to 12 weeks.
As one of the few liquid alkaloids, nicotine constitutes about 5 percent of a tobacco plant by weight. While nicotine is found throughout the tobacco plant, it occurs in the highest concentrations in the leaves, and ranges from 1 to 8 percent by weight in a typical cigarette. 350c69d7ab